About N-(2-tert-butylsulfonylethyl)-N-[(1R)-1-[1-(4-cyanophenyl)-5-fluorobenzimidazol-2-yl]ethyl]-2-[4-fluoro-3-(trifluoromethyl)phenyl]acetamide
N-(2-tert-butylsulfonylethyl)-N-[(1R)-1-[1-(4-cyanophenyl)-5-fluorobenzimidazol-2-yl]ethyl]-2-[4-fluoro-3-(trifluoromethyl)phenyl]acetamide (PubChem CID 11628788) has the molecular formula C31H29F5N4O3S
and a molecular weight of 632.66 g/mol. Its IUPAC name is N-(2-tert-butylsulfonylethyl)-N-[(1R)-1-[1-(4-cyanophenyl)-5-fluorobenzimidazol-2-yl]ethyl]-2-[4-fluoro-3-(trifluoromethyl)phenyl]acetamide.
Molecular Properties
| Compound Name | N-(2-tert-butylsulfonylethyl)-N-[(1R)-1-[1-(4-cyanophenyl)-5-fluorobenzimidazol-2-yl]ethyl]-2-[4-fluoro-3-(trifluoromethyl)phenyl]acetamide |
| PubChem CID | 11628788 |
| Molecular Formula | C31H29F5N4O3S |
| Molecular Weight | 632.66 g/mol |
| Exact Mass | 632.19 |
| IUPAC Name | N-(2-tert-butylsulfonylethyl)-N-[(1R)-1-[1-(4-cyanophenyl)-5-fluorobenzimidazol-2-yl]ethyl]-2-[4-fluoro-3-(trifluoromethyl)phenyl]acetamide |
| SMILES | C[C@H](c1nc2cc(F)ccc2n1-c1ccc(C#N)cc1)N(CCS(=O)(=O)C(C)(C)C)C(=O)Cc1ccc(F)c(C(F)(F)F)c1 |
| InChI | InChI=1S/C31H29F5N4O3S/c1-19(29-38-26-17-22(32)8-12-27(26)40(29)23-9-5-20(18-37)6-10-23)39(13-14-44(42,43)30(2,3)4)28(41)16-21-7-11-25(33)24(15-21)31(34,35)36/h5-12,15,17,19H,13-14,16H2,1-4H3/t19-/m1/s1 |
| InChIKey | OBHFGHOGKAHNMV-LJQANCHMSA-N |
| XLogP | 6.54 |
| TPSA | 96.06 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 44 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 632.66 |
| LogP ≤ 5 | 6.54 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Analyze N-(2-tert-butylsulfonylethyl)-N-[(1R)-1-[1-(4-cyanophenyl)-5-fluorobenzimidazol-2-yl]ethyl]-2-[4-fluoro-3-(trifluoromethyl)phenyl]acetamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-(2-tert-butylsulfonylethyl)-N-[(1R)-1-[1-(4-cyanophenyl)-5-fluorobenzimidazol-2-yl]ethyl]-2-[4-fluoro-3-(trifluoromethyl)phenyl]acetamide?
The IUPAC name of N-(2-tert-butylsulfonylethyl)-N-[(1R)-1-[1-(4-cyanophenyl)-5-fluorobenzimidazol-2-yl]ethyl]-2-[4-fluoro-3-(trifluoromethyl)phenyl]acetamide (CID 11628788) is N-(2-tert-butylsulfonylethyl)-N-[(1R)-1-[1-(4-cyanophenyl)-5-fluorobenzimidazol-2-yl]ethyl]-2-[4-fluoro-3-(trifluoromethyl)phenyl]acetamide.
What is the SMILES notation for N-(2-tert-butylsulfonylethyl)-N-[(1R)-1-[1-(4-cyanophenyl)-5-fluorobenzimidazol-2-yl]ethyl]-2-[4-fluoro-3-(trifluoromethyl)phenyl]acetamide?
The canonical SMILES for N-(2-tert-butylsulfonylethyl)-N-[(1R)-1-[1-(4-cyanophenyl)-5-fluorobenzimidazol-2-yl]ethyl]-2-[4-fluoro-3-(trifluoromethyl)phenyl]acetamide is C[C@H](c1nc2cc(F)ccc2n1-c1ccc(C#N)cc1)N(CCS(=O)(=O)C(C)(C)C)C(=O)Cc1ccc(F)c(C(F)(F)F)c1.
What is the InChIKey of N-(2-tert-butylsulfonylethyl)-N-[(1R)-1-[1-(4-cyanophenyl)-5-fluorobenzimidazol-2-yl]ethyl]-2-[4-fluoro-3-(trifluoromethyl)phenyl]acetamide?
The InChIKey is OBHFGHOGKAHNMV-LJQANCHMSA-N. The full InChI is InChI=1S/C31H29F5N4O3S/c1-19(29-38-26-17-22(32)8-12-27(26)40(29)23-9-5-20(18-37)6-10-23)39(13-14-44(42,43)30(2,3)4)28(41)16-21-7-11-25(33)24(15-21)31(34,35)36/h5-12,15,17,19H,13-14,16H2,1-4H3/t19-/m1/s1.
What are the key properties of N-(2-tert-butylsulfonylethyl)-N-[(1R)-1-[1-(4-cyanophenyl)-5-fluorobenzimidazol-2-yl]ethyl]-2-[4-fluoro-3-(trifluoromethyl)phenyl]acetamide?
N-(2-tert-butylsulfonylethyl)-N-[(1R)-1-[1-(4-cyanophenyl)-5-fluorobenzimidazol-2-yl]ethyl]-2-[4-fluoro-3-(trifluoromethyl)phenyl]acetamide has a molecular weight of 632.66 g/mol, XLogP of 6.54, 8 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-(2-tert-butylsulfonylethyl)-N-[(1R)-1-[1-(4-cyanophenyl)-5-fluorobenzimidazol-2-yl]ethyl]-2-[4-fluoro-3-(trifluoromethyl)phenyl]acetamide is sourced from PubChem (CID 11628788), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).